These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 21728008)

  • 21. Establishment and characterization of a new human prostatic cancer cell line: DuCaP.
    Lee YG; Korenchuk S; Lehr J; Whitney S; Vessela R; Pienta KJ
    In Vivo; 2001; 15(2):157-62. PubMed ID: 11317521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Establishing prostate cancer patient derived xenografts: lessons learned from older studies.
    Russell PJ; Russell P; Rudduck C; Tse BW; Williams ED; Raghavan D
    Prostate; 2015 May; 75(6):628-36. PubMed ID: 25560784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adenovirus p16 gene therapy for prostate cancer.
    Allay JA; Steiner MS; Zhang Y; Reed CP; Cockroft J; Lu Y
    World J Urol; 2000 Apr; 18(2):111-20. PubMed ID: 10854145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Three-dimensional cultures of prostatic cells: tissue models for the development of novel anti-cancer therapies.
    O'Connor KC
    Pharm Res; 1999 Apr; 16(4):486-93. PubMed ID: 10227701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo model mimicking natural history of dog prostate cancer using DPC-1, a new canine prostate carcinoma cell line.
    Anidjar M; Villette JM; Devauchelle P; Delisle F; Cotard JP; Billotey C; Cochand-Priollet B; Copin H; Barnoux M; Triballeau S; Rain JD; Fiet J; Teillac P; Berthon P; Cussenot O
    Prostate; 2001 Jan; 46(1):2-10. PubMed ID: 11170126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone.
    Nemeth JA; Harb JF; Barroso U; He Z; Grignon DJ; Cher ML
    Cancer Res; 1999 Apr; 59(8):1987-93. PubMed ID: 10213511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A 3D in vitro model of patient-derived prostate cancer xenograft for controlled interrogation of in vivo tumor-stromal interactions.
    Fong EL; Wan X; Yang J; Morgado M; Mikos AG; Harrington DA; Navone NM; Farach-Carson MC
    Biomaterials; 2016 Jan; 77():164-72. PubMed ID: 26599623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Animal models of bone metastasis.
    Rosol TJ; Tannehill-Gregg SH; LeRoy BE; Mandl S; Contag CH
    Cancer; 2003 Feb; 97(3 Suppl):748-57. PubMed ID: 12548572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of curcumin on the invasiveness of prostate cancer in vitro and in vivo.
    Hong JH; Ahn KS; Bae E; Jeon SS; Choi HY
    Prostate Cancer Prostatic Dis; 2006; 9(2):147-52. PubMed ID: 16389264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel mouse model of human prostate cancer to study intraprostatic tumor growth and the development of lymph node metastases.
    Linxweiler J; Körbel C; Müller A; Hammer M; Veith C; Bohle RM; Stöckle M; Junker K; Menger MD; Saar M
    Prostate; 2018 Jun; 78(9):664-675. PubMed ID: 29572953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of nude mouse xenograft models in prostate cancer research.
    van Weerden WM; Romijn JC
    Prostate; 2000 Jun; 43(4):263-71. PubMed ID: 10861745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nanomicellar TGX221 blocks xenograft tumor growth of prostate cancer in nude mice.
    Chen R; Zhao Y; Huang Y; Yang Q; Zeng X; Jiang W; Liu J; Thrasher JB; Forrest ML; Li B
    Prostate; 2015 May; 75(6):593-602. PubMed ID: 25620467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glutathione and glutathione S-transferase in benign and malignant prostate cell lines and prostate tissues.
    Canada AT; Roberson KM; Vessella RL; Trump DL; Robertson CN; Fine RL
    Biochem Pharmacol; 1996 Jan; 51(1):87-90. PubMed ID: 8534273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential expression of uPA in an aggressive (DU 145) and a nonaggressive (1013L) human prostate cancer xenograft.
    Billström A; Lecander I; Dagnaes-Hansen F; Dahllöf B; Stenram U; Hartley-Asp B
    Prostate; 1995 Feb; 26(2):94-104. PubMed ID: 7531848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Establishing human prostate cancer cell xenografts in bone: induction of osteoblastic reaction by prostate-specific antigen-producing tumors in athymic and SCID/bg mice using LNCaP and lineage-derived metastatic sublines.
    Wu TT; Sikes RA; Cui Q; Thalmann GN; Kao C; Murphy CF; Yang H; Zhau HE; Balian G; Chung LW
    Int J Cancer; 1998 Sep; 77(6):887-94. PubMed ID: 9714059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo models of human prostate cancer bone metastasis.
    Brown JM
    Methods Mol Med; 2003; 81():149-62. PubMed ID: 12725119
    [No Abstract]   [Full Text] [Related]  

  • 37. Model systems of prostate cancer: uses and limitations.
    Navone NM; Logothetis CJ; von Eschenbach AC; Troncoso P
    Cancer Metastasis Rev; 1998-1999; 17(4):361-71. PubMed ID: 10453280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conditionally reprogrammed normal and primary tumor prostate epithelial cells: a novel patient-derived cell model for studies of human prostate cancer.
    Timofeeva OA; Palechor-Ceron N; Li G; Yuan H; Krawczyk E; Zhong X; Liu G; Upadhyay G; Dakic A; Yu S; Fang S; Choudhury S; Zhang X; Ju A; Lee MS; Dan HC; Ji Y; Hou Y; Zheng YL; Albanese C; Rhim J; Schlegel R; Dritschilo A; Liu X
    Oncotarget; 2017 Apr; 8(14):22741-22758. PubMed ID: 28009986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppression of primary tumor growth and the progression to metastasis with p53 adenovirus in human prostate cancer.
    Eastham JA; Grafton W; Martin CM; Williams BJ
    J Urol; 2000 Sep; 164(3 Pt 1):814-9. PubMed ID: 10953161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene transfer of alpha1,3-fucosyltransferase increases tumor growth of the PC-3 human prostate cancer cell line through enhanced adhesion to prostatic stromal cells.
    Inaba Y; Ohyama C; Kato T; Satoh M; Saito H; Hagisawa S; Takahashi T; Endoh M; Fukuda MN; Arai Y; Fukuda M
    Int J Cancer; 2003 Dec; 107(6):949-57. PubMed ID: 14601054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.